David DeLucia - Dec 16, 2024 Form 3 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Financial Officer
Signature: /s/ /s/Michael Hom, Attorney-in-Fact
Stock symbol: FGEN
Transactions as of: Dec 16, 2024
Transactions value $: $0
Form type: 3
Date filed: 12/18/2024, 05:01 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	FGEN	Common Stock						118K	Dec 16, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FGEN	Stock Option (Right to Buy)							Dec 16, 2024	Common Stock	41.1K	$9.99	Direct	F1
holding	FGEN	Stock Option (Right to Buy)							Dec 16, 2024	Common Stock	13.6K	$22.60	Direct	F2
holding	FGEN	Stock Option (Right to Buy)							Dec 16, 2024	Common Stock	100K	$1.21	Direct	F3
holding	FGEN	Stock Option (Right to Buy)							Dec 16, 2024	Common Stock	44K	$1.89	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent of the shares subject to the option vested on May 2, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F2	Twenty-five percent of the shares subject to the option vested on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F3	Twenty-five percent of the shares subject to the option vested on September 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
F4	Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.